Pivotal Research Thinks Herbalife’s Stock is Going to Recover


Pivotal Research analyst Timothy Ramey maintained a Buy rating on Herbalife (HLF) today and set a price target of $65. The company’s shares closed yesterday at $40.76, close to its 52-week low of $39.36.

Ramey said:

“Well, that all worked out fine; the HLF share price is down 31% in the past year. In two weeks, HLF will pay off its $671 million of converts, ending the perverse disincentive to create a higher share price.”

According to TipRanks.com, Ramey is a 4-star analyst with an average return of 5.9% and a 54.9% success rate. Ramey covers the Consumer Goods sector, focusing on stocks such as Constellation Brands Inc, Post Holdings Inc, and Brown-Forman B.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Herbalife with a $62 average price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $61.77 and a one-year low of $39.36. Currently, Herbalife has an average volume of 2.29M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Herbalife Nutrition Ltd. is a holding company, which engages in the development and sale of nutrition solutions. It operates through the following segments: North America; Mexico; South and Central America; Europe, Middle East, and Africa; Asia pacific; and China.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts